ישראל - עברית - Ministry of Health

רידנט-נובה בע"מ - רופא שיניים - the self adjusting file (saf) is a mechanically operated endodontic file to be used for cleaning and shaping of root canals , as part of procedure of root canal treatment

ישראל - עברית - Ministry of Health

נאופרם ציוד רפואי ומסחר 1997 בע"מ - רופא - טבעת לקיצור קיבה

ישראל - עברית - Ministry of Health

rekah pharmaceutical industry ltd, israel - nortriptyline hydrochloride - טבליה - nortriptyline hydrochloride 25 mg - nortriptyline - nortriptyline - depressive states, endogenous depressions are more likely to be alleviated than other depressive states.

ישראל - עברית - Ministry of Health

astrazeneca (israel) ltd - a/darwin/9/2021 (h3n2)-like virus; a/victoria/4897/2022 (h1n1)pdm09-like virus; b/austria/1359417/2021 (b/victoria lineage)-like virus; b/phuket/3073/2013 (b/yamagata lineage)-like virus - ספריי לאף - b/phuket/3073/2013 (b/yamagata lineage)-like virus 7 ±0.5 log10 ffu^a / 0.2 ml; a/darwin/9/2021 (h3n2)-like virus 7 ±0.5 log10 ffu^a / 0.2 ml; b/austria/1359417/2021 (b/victoria lineage)-like virus 7 ±0.5 log10 ffu^a / 0.2 ml; a/victoria/4897/2022 (h1n1)pdm09-like virus 7 ±0.5 log10 ffu^a / 0.2 ml - influenza, inactivated, split virus or surface antigen - influenza, purified antigen - flumist quadrivalent is a vaccine indicated for active immunization for the prevention of influenza disease caused by influenza a subtype viruses ad type b viruses contained in the vaccine. flumist quadrivalent is approved for use in persons 2 through 49 years of age.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - a/darwin/9/2021 (h3n2)-like virus; a/victoria/4897/2022 (h1n1)pdm09-like virus; b/austria/1359417/2021 (b/victoria lineage)-like virus; b/phuket/3073/2013 (b/yamagata lineage)-like virus - תרחיף להזרקה - b/phuket/3073/2013 (b/yamagata lineage)-like virus 30 mcg ha / 1 ml; b/austria/1359417/2021 (b/victoria lineage)-like virus 30 mcg ha / 1 ml; a/darwin/9/2021 (h3n2)-like virus 30 mcg ha / 1 ml; a/victoria/4897/2022 (h1n1)pdm09-like virus 30 mcg ha / 1 ml - influenza, inactivated, split virus or surface antigen

ישראל - עברית - Ministry of Health

teva pharmaceutical indust.ltd - levofloxacin hemihydrate 250 mg - tablets - levofloxacin - in adults with infections of mild to moderate severity levofloxacin teva tablets are indicated for the treatment of the following infections when due to levofloxacin - susceptible micro-organisms: - acute sinusitis. - acute exacerbation of chronic bronchitis. - community-acquired pneumonia. - complicated urinary tract infections including pyelonephritis. - skin and soft tissue infections.

ישראל - עברית - Ministry of Health

teva pharmaceutical indust.ltd - levofloxacin hemihydrate 500 mg - tablets - levofloxacin - in adults with infections of mild to moderate severity levofloxacin teva tablets are indicated for the treatment of the following infections when due to levofloxacin - susceptible micro-organisms: - acute sinusitis. - acute exacerbation of chronic bronchitis. - community-acquired pneumonia. - complicated urinary tract infections including pyelonephritis. - skin and soft tissue infections.

ישראל - עברית - Ministry of Health

teva pharmaceutical indust.ltd - levetiracetam 250 mg - tablets - levetiracetam - - levetiracetam is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - levetiracetam is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy.- levetiracetam is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patient from 16 years of age with newly diagnosed epilepsy.- levetiracetam is indicated in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

ישראל - עברית - Ministry of Health

teva pharmaceutical indust.ltd - levetiracetam 500 mg - tablets - levetiracetam - - levetiracetam is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - levetiracetam is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy.- levetiracetam is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patient from 16 years of age with newly diagnosed epilepsy.- levetiracetam is indicated in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

ישראל - עברית - Ministry of Health

teva pharmaceutical indust.ltd - levetiracetam 1000 mg - tablets - levetiracetam - - levetiracetam is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - levetiracetam is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy.- levetiracetam is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patient from 16 years of age with newly diagnosed epilepsy.- levetiracetam is indicated in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.